MGI(SH:688114) Zheng Quan Shi Bao Wang·2025-07-24 12:22Group 1 - The World Health Organization (WHO) experts issued a warning on July 22 regarding the chikungunya virus, urging countries to prepare for potential outbreaks and emphasizing the importance of mosquito control and source identification [1] - The Shenzhen CDC and BGI Genomics collaborated using the DNBSEQ T1+ sequencing platform to trace the chikungunya virus in infected individuals, achieving over 99.9% coverage in sequencing [1] - The T1+ sequencing instrument supports rapid and precise virus tracing, enabling public health authorities to develop effective control strategies [1] Group 2 - The T1+ is recognized as the fastest desktop Tb-level sequencer globally, capable of producing complete genomes from low-load, diverse virus samples without the need for culture [2] - It can generate Tb-level data within 24 hours and features automated operations, integrating sequencing and bioinformatics analysis into a closed-loop process [2] - The T1+ provides a comprehensive automated workflow for infectious disease control, meeting the core demands of public health for precision, speed, and simplicity [2] Group 3 - Multiple customs authorities are utilizing the CycloneSEQ platform for full genome sequencing of the chikungunya virus to control imported cases [3] - The CycloneSEQ platform achieves 100% coverage in sequencing results, matching those obtained from the DNBSEQ platform, and offers real-time monitoring of high-density samples at entry points [3] - BGI Genomics is the only company globally to offer both short-read (DNBSEQ) and long-read (CycloneSEQ) sequencing products, catering to diverse monitoring and control needs for pathogenic microorganisms [3]